Valuation: Perrigo Company plc

Market Cap 2.2B 1.97B 1.8B 1.65B 3.1B 207B 3.2B 21.74B 8.67B 110B 8.26B 8.08B 348B P/E 2026 *
-3.87x
P/E 2027 * 63.4x
Enterprise Value 5.21B 4.68B 4.27B 3.9B 7.35B 490B 7.58B 51.52B 20.54B 262B 19.57B 19.15B 826B EV / Sales 2026 *
1.3x
EV / Sales 2027 * 1.29x
Free-Float
99.61%
Yield 2026 *
7.32%
Yield 2027 * 7.41%
1 day+0.89%
1 week+0.44%
Current month+0.44%
1 month+13.21%
3 months+26.40%
6 months+29.28%
Current year+13.86%
1 week 15.12
Extreme 15.12
16.8
1 month 14.1
Extreme 14.1
16.8
Current year 9.22
Extreme 9.225
16.8
1 year 9.22
Extreme 9.225
16.8
3 years 9.22
Extreme 9.225
34.6
5 years 9.22
Extreme 9.225
47.95
10 years 9.22
Extreme 9.225
95.93
Manager TitleAgeSince
Chief Executive Officer 63 2026-06-06
Director of Finance/CFO 51 2022-05-15
Chief Operating Officer - 2025-06-22
Director TitleAgeSince
Director/Board Member 75 2014-10-31
Director/Board Member 61 2016-11-06
Director/Board Member 70 2017-02-05
Date Insider Type Main position Quantity % Market Cap. Importance
9/11/26 Exercice

Director

5,192 0.0037%
9/11/26 Exercice

Director

3,133 0.0023%
9/9/26 Exercice

Executive/Senior Manager

18,186 0.0131%
Change 5-day change 1-year change 3-year change Capi.($)
+0.89%+0.44%+6.16%-44.33% 2.2B
-0.79%-4.48%+44.44%+127.49% 1,206B
+1.43%+1.11%+47.73%+82.08% 665B
+1.07%-1.21%+32.99%+106.31% 515B
-0.36%-3.25%+47.17%+64.58% 381B
-0.14%-1.87%+71.05%+40.63% 362B
-0.78%-0.52%+30.57%+57.98% 307B
-0.80%-0.21%+8.54%+35.56% 289B
+0.03%-1.20%+45.89%+68.76% 249B
-0.41%-2.22%+35.24%+105.68% 207B
Average +0.01%-1.34%+36.98%+64.47% 418.19B
Weighted average by Cap. -0.04%-1.96%+42.22%+88.31%

Financials

2026 *2027 *
Net sales 4.01B 3.59B 3.28B 3B 5.65B 377B 5.83B 39.58B 15.78B 201B 15.04B 14.71B 634B 3.87B 3.47B 3.17B 2.9B 5.46B 364B 5.63B 38.25B 15.25B 194B 14.53B 14.22B 613B
Net income -573M -514M -470M -429M -808M -53.86B -833M -5.66B -2.26B -28.74B -2.15B -2.1B -90.73B 35M 31.39M 28.69M 26.19M 49.34M 3.29B 50.9M 346M 138M 1.76B 131M 129M 5.54B
Net Debt 3.01B 2.7B 2.47B 2.26B 4.25B 283B 4.38B 29.78B 11.88B 151B 11.31B 11.07B 477B 2.8B 2.51B 2.29B 2.09B 3.95B 263B 4.07B 27.65B 11.02B 140B 10.5B 10.28B 443B
Projected Income Statement - Annual - Perrigo Company plc
Logo Perrigo Company plc
Perrigo Company plc is a pure-play self-care company. The Company provides health and wellness solutions. Its segments include Self Care, Specialty Care, and Infant Formula. Self Care comprises Upper Respiratory, Digestive Health, Pain & Sleep and Healthy Lifestyle product categories globally. Specialty Care comprises our Women's Health and Skin Health product categories globally. Infant Formula comprises the Infant Formula product category, which includes nutritional products designed to meet the dietary needs of infants. It provides a store-branded private label provider of self-care products in many categories, including upper respiratory, healthy lifestyle and women's health, along with brands including Opill and Mederma. Its Europe portfolio consists primarily of brands, including Compeed, ellaOne, Solpadeine, Jungle Formula, and ACO. Its upper respiratory products include Nasonex 24HR Energy, Mucus DM, All Day Allergy, Nighttime Cold & Flu, and Allergy Relief.
Employees
8,100
Date Price Change Volume
26-11-06 $15.85 +0.89% 2,314,636
26-11-05 $15.71 -0.76% 2,875,543
26-11-04 $15.83 +0.83% 4,972,088
26-11-03 $15.70 -0.32% 2,146,726
26-11-02 $15.75 -0.19% 2,007,463
Trader
Investor
Global
Quality
ESG MSCI
BB
MarketScreener Ratings - Perrigo Company plc
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
4
Last Close Price
15.85USD
Average target price
18.00USD
Spread / Average Target
+13.56%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Perrigo Company plc
  1. Stock Market
  2. Stocks
  3. PRGO Stock